Moderna mRNA cancer therapy hits Ph3 endpoints; AI builds next-gen bio engines
timshi_ai · x · 2026-08-20
Moderna's mRNA cancer therapy combined with Keytruda met its Phase 3 endpoints. Kerna Labs reiterated their thesis that mRNA will become a widespread therapeutic modality beyond vaccines, noting they are already building foundation models and in vivo data engines for what comes next.
Related event: Moderna's AI-Designed Personalized mRNA Cancer Vaccine Wins Phase III(23 posts)→
More from Companies & People
- AI companies should share abundance to welcome communities — PeterDiamandis · 2026-08-20
- Rust Compiler Contributor Sets Goal: Make rustc 10x Faster — mitsuhiko · 2026-08-20
- Google Cloud to hire hundreds of forward-deployed AI engineers for enterprise support — Justgototheeffinmoon · 2026-08-20
- Dev jokes about borrowing GPUs to speed up project, pitches architecture to Microsoft — doodlestein · 2026-08-20
- Wayve launches early access rides with Uber in London — alexgkendall · 2026-08-20
- Elon Musk teases SuperGrok launch: 'Let's build the future' — Brian821 · 2026-08-20